Celebrity Pet‑Cloning Normalizes Grief Commodification

High‑profile endorsements and acquisitions are turning pet cloning from an experimental biotech niche into a mainstream, luxury grief service (e.g., Tom Brady + Colossal buying Viagen). That shift reframes mourning as a purchasable continuity, creating new markets, status signals, animal‑welfare issues, and pressure on regulators to set ethical boundaries. — If cloning pets becomes culturally normalized, it will reshape consumer expectations about death, drive legislative and regulatory responses, and concentrate moral‑hazard dynamics where wealthy actors set norms that later diffuse to broader populations.